Finance Watch: Third Harmonic Launches The Largest IPO In Months
Positive Readouts, An Approval Spur Follow-On Offerings
Biopharma stock prices overall are trending down again, but standout firms are raising cash, including the first company to price an IPO over $100m since May, Third Harmonic. Also, Sarepta and Alnylam launched large note offerings, totaling $1bn and $900m, respectively.
